目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T77718 | FAK | ||
FAK-IN-10 是一种 FAK 的抑制剂(IC50:76.3 μM)。FAK-IN-10 z MCF-7 和 A431 细胞系中显示出抗肿瘤活性,IC50 分别为 4.23 和 0.78 μM 。 | |||
T5155 | EGFR | ||
(E)-AG 99 ((E)-Tyrphostin AG 99) 是一种 EGFR 抑制剂。 | |||
T64124 | EGFR BTK | ||
Sunvozertinib (DZD9008) 是一种有效的 ErbBs 和 BTK 抑制剂,对EGFR、Her2和突变型表皮生长因子有抑制作用。 Sunvozertinib 显示 EGFR 外显子 20 NPH 插入、EGFR 外显子 20 ASV 插入、EGFR L858R 和 T790M 突变以及 Her2 外显子 20 YVMA 和 EGFR WT A431 有抑制作用, IC50 分别为 20.4、20.4、1.1、7.5 和 80.4 nM 。 | |||
T2S0961 | EGFR Antibacterial | ||
Chalcone (Cinnamophenone) 是从甘草中分离得到的一种芳香酮,可合成查耳酮衍生物。它具有多种生物和药理的活性,如抗炎、抗菌、抗癌、抗氧化、抗寄生虫等活性。 | |||
TN6569 | |||
cis-Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells. | |||
T8525 | EGFR FGFR | ||
EGFR-IN-16 (AG473) 是一种EGFR 抑制剂,对 EGFR 和 HER-2 的pIC50分别为4.85和4.74。 | |||
T60314 | |||
Anticancer agent 38 (compound 19) 是芳基脲化合物,是一种有效的抗癌剂。Anticancer agent 38 抑制 A431 细胞生长的 IC50为 5.2 μg/mL。 | |||
T9905 | EGFR | ||
Cetuximab (C225) 属于单克隆抗体,是一种人源表皮生长因子受体 (EGFR) 的抑制剂 (Kd=0.201 nM)。Cetuximab 具有抗肿瘤活性,可以抑制肿瘤细胞增殖,诱导细胞凋亡。 | |||
T79888 | EGFR | ||
EGFR-IN-87 为EGFR酪氨酸激酶抑制剂,针对A431细胞中EGFR_d746-750, EGFR_L858R/T790M 及 EGFR_WT 具有IC50值分别约为3.1 nM、1.3 nM和7.1 nM,适用于癌症疾病研究。 | |||
T73101 | |||
EGFR-IN-25 是一种有效的EGFR 抑制剂,对 BaF3 细胞 (EGFR DEL19/T790M/C797S) 和 A431 细胞 (WT) 的IC50分别为 9 nM 和 60 nM。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-00978 | Progranulin Protein, Human, Recombinant (His) | Human | HEK293 | ||
Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif. The precursor protein, progranulin, is also called Proepithelin and PC cell-derived growth factor. Cleavage of the signal peptide produces mature granulin which can be further cleaved into a variety of active, 6 kDa peptides. These smaller cleavage products are named granulin A, granulin B, granulin C, etc. Epithelins 1 and 2 are synonymous with granulins A and B, respectively. Both the peptides and intact granulin protein regulate cell growth. However, different members of the granulin protein family may act as inhibitors, stimulators, or have dual actions on cell growth. Granulin family members are important in normal development, wound healing, and tumorigenesis. Granulins have possible cytokine-like activity. They may play a role in inflammation, wound repair, and tissue remodeling. Granulin-4 promotes proliferation of the epithelial cell line A431 in culture while granulin-3 acts as an antagonist to granulin-4, inhibiting the growth. Granulin expression inhibited Tat transactivation, and tethering experiments showed that this effect was due, at least in part, to a direct action on cyclin T1 in the absence of Tat.
|
|||||
TMPY-02166 | Epiregulin Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 | ||
Epiregulin (EREG) is a member of the epidermal growth factor family. Epiregulin (EREG) can function as a ligand of EGFR (epidermal growth factor receptor), as well as a ligand of most members of the ERBB (v-erb-b2 oncogene homolog) family of tyrosine-kinase receptors. Epiregulin (EREG) exhibit bifunctional regulatory properties: it inhibit the growth of several epithelial tumor cells and stimulated the growth of fibroblasts and various other types of cells. Epiregulin (EREG) bound to the EGF receptors of epidermoid carcinoma A431 cells much more weakly than did EGF, but was nevertheless much more potent than EGF as a mitogen for rat primary hepatocytes and Balb/c 3T3 A31 fibroblasts. These findings suggest that epiregulin (EREG) plays important roles in regulating the growth of epithelial cells and fibroblasts by binding to receptors for EGF-related ligands. Epiregulin (EREG) is the broadest specificity EGF-like ligand so far characterized: not only does it stimulate homodimers of both ErbB-1 and ErbB-4, it also activates all possible heterodimeric ErbB complexes.
|
|||||
TMPY-02169 | Epiregulin Protein, Human, Recombinant (hFc) | Human | HEK293 | ||
Epiregulin (EREG) is a member of the epidermal growth factor family. Epiregulin (EREG) can function as a ligand of EGFR (epidermal growth factor receptor), as well as a ligand of most members of the ERBB (v-erb-b2 oncogene homolog) family of tyrosine-kinase receptors. Epiregulin (EREG) exhibit bifunctional regulatory properties: it inhibit the growth of several epithelial tumor cells and stimulated the growth of fibroblasts and various other types of cells. Epiregulin (EREG) bound to the EGF receptors of epidermoid carcinoma A431 cells much more weakly than did EGF, but was nevertheless much more potent than EGF as a mitogen for rat primary hepatocytes and Balb/c 3T3 A31 fibroblasts. These findings suggest that epiregulin (EREG) plays important roles in regulating the growth of epithelial cells and fibroblasts by binding to receptors for EGF-related ligands. Epiregulin (EREG) is the broadest specificity EGF-like ligand so far characterized: not only does it stimulate homodimers of both ErbB-1 and ErbB-4, it also activates all possible heterodimeric ErbB complexes.
|
|||||
TMPY-01435 | Progranulin Protein, Mouse, Recombinant (His) | Mouse | HEK293 | ||
Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif. The precursor protein, progranulin, is also called Proepithelin and PC cell-derived growth factor. Cleavage of the signal peptide produces mature granulin which can be further cleaved into a variety of active, 6 kDa peptides. These smaller cleavage products are named granulin A, granulin B, granulin C, etc. Epithelins 1 and 2 are synonymous with granulins A and B, respectively. Both the peptides and intact granulin protein regulate cell growth. However, different members of the granulin protein family may act as inhibitors, stimulators, or have dual actions on cell growth. Granulin family members are important in normal development, wound healing, and tumorigenesis. Granulins have possible cytokine-like activity. They may play a role in inflammation, wound repair, and tissue remodeling. Granulin-4 promotes proliferation of the epithelial cell line A431 in culture while granulin-3 acts as an antagonist to granulin-4, inhibiting the growth. Granulin expression inhibited Tat transactivation, and tethering experiments showed that this effect was due, at least in part, to a direct action on cyclin T1 in the absence of Tat.
|